Prevalence and diagnosis of primary aldosteronism

Current Hypertension Reports

Volumn 12, Issue 5, 2010, Pages 342-348

  Rossi, Gian Paolo ^a  

^a UNIVERSITY HOSPITAL OF PADOVA   (Italy)

Author keywords

Adrenal vein sampling; Aldosterone; Aldosterone renin ratio; Aldosteronism; Case detection; Conn's syndrome; Diagnosis; Endocrine hypertension; Prevalence; Primary aldosteronism; Renin; Screening; Treatment

Indexed keywords

ALDOSTERONE;

ADRENALECTOMY; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST; DISEASE CLASSIFICATION; EPIDEMIOLOGICAL DATA; HUMAN; HYPERTENSION; PATIENT ASSESSMENT; PATIENT CARE; PLASMA RENIN ACTIVITY; PRIMARY HYPERALDOSTERONISM; REVIEW; SCREENING TEST; SENSITIVITY AND SPECIFICITY;

EID: 77958450472     PISSN: 15226417     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11906-010-0134-2     Document Type: Review

References (50)

1. JW Conn 1955 Presidential address. I. Painting background. II. Primary aldosteronism, a new clinical syndrome J Lab Clin Med 45 3 17 1:CAS:528:DyaG2MXitFSjsQ%3D%3D 13233623
2. GP Rossi 2006 Surgically correctable hypertension caused by primary aldosteronism Best Pract Res Clin Endocrinol Metab 20 385 400 1:CAS:528:DC%2BD28Xps1CntLw%3D 10.1016/j.beem.2006.07.003 16980201 (Pubitemid 44356451)
3. N Schupp N Queisser M Wolf, et al. 2010 Aldosterone causes DNA strand breaks and chromosomal damage in renal cells, which are prevented by mineralocorticoid receptor antagonists Horm Metab Res 42 458 465 1:CAS:528:DC%2BC3cXpslSjtbg%3D 10.1055/s-0029-1243253 20094972 This study shows that aldosterone causes oxidative DNA damage, which could be prevented by MR antagonists
4. R Rocha AE Rudolph GE Frierdich, et al. 2002 Aldosterone induces a vascular inflammatory phenotype in the rat heart Am J Physiol Heart Circ Physiol 283 H1802 H1810 1:CAS:528:DC%2BD38XovVOmt74%3D 12384457
5. CG Brilla B Maisch KT Weber 1992 Myocardial collagen matrix remodelling in arterial hypertension Eur Heart J 13 Suppl D 24 32 1:CAS:528: DyaK3sXpvFSqsw%3D%3D 1396856
6. GP Rossi A Sacchetto E Pavan, et al. 1997 Remodeling of the left ventricle in primary aldosteronism due to Conn's adenoma Circulation 95 1471 1478 1:STN:280:DyaK2s3jsVSitQ%3D%3D 9118515
7. GP Rossi V Di Bello C Ganzaroli, et al. 2002 Excess aldosterone is associated with alterations of myocardial texture in primary aldosteronism Hypertension 40 23 27 1:CAS:528:DC%2BD38XlsVGisLs%3D 10.1161/01.HYP.0000023182. 68420.EB 12105133 (Pubitemid 34755974)
8. CA Farquharson AD Struthers 2002 Aldosterone induces acute endothelial dysfunction in vivo in humans: evidence for an aldosterone-induced vasculopathy Clin Sci (Lond) 103 425 431 1:CAS:528:DC%2BD38XotVWltb8%3D
9. D Rizzoni ML Muiesan E Porteri, et al. 1998 Relations between cardiac and vascular structure in patients with primary and secondary hypertension J Am Coll Cardiol 32 985 992 1:STN:280:DyaK1cvjvFKmug%3D%3D 10.1016/S0735-1097(98) 00322-2 9768722 (Pubitemid 28459589)
10. GP Rossi G Bernini G Desideri, et al. 2006 Renal damage in primary aldosteronism: results of the PAPY study Hypertension 48 232 238 1:CAS:528:DC%2BD28XmvFalurg%3D 10.1161/01.HYP.0000230444.01215.6a 16801482 (Pubitemid 44309817)
11. GP Rossi LA Sechi G Giacchetti, et al. 2008 Primary aldosteronism: cardiovascular, renal and metabolic implications Trends Endocrinol Metab 19 88 90 1:CAS:528:DC%2BD1cXktV2iu7Y%3D 10.1016/j.tem.2008.01.006 18314347 This review article provides updated information on the involvement of excess aldosterone in causing target organ damage in hypertension and in worsening the prognosis of patients with heart failure and post-MI patients (Pubitemid 351442920)
12. LA Sechi M Novello R Lapenna, et al. 2006 Long-term renal outcomes in patients with primary aldosteronism JAMA 295 2638 2645 1:CAS:528: DC%2BD28XlvFWmtbo%3D 10.1001/jama.295.22.2638 16772627 (Pubitemid 43882339)
13. P Milliez X Girerd PF Plouin, et al. 2005 Evidence for an increased rate of cardiovascular events in patients with primary aldosteronism J Am Coll Cardiol 45 1243 1248 1:CAS:528:DC%2BD2MXjtlagt70%3D 10.1016/j.jacc.2005.01.015 15837256 (Pubitemid 40523144)
14. GP Rossi M Bolognesi D Rizzoni, et al. 2008 Vascular remodeling and duration of hypertension predict outcome of adrenalectomy in primary aldosteronism patients Hypertension 51 1366 1371 1:CAS:528:DC%2BD1cXktlylsb4%3D 10.1161/HYPERTENSIONAHA.108.111369 18347224 This paper provides solid information on the effect of adrenalectomy on hyperaldosteronism and blood pressure when the patients are selected for adrenalectomy based on demonstration of lateralized aldosterone excess. It also identifies the predictors of the blood pressure outcome (Pubitemid 351555951)
15. C Catena G Colussi R Lapenna, et al. 2007 Long-term cardiac effects of adrenalectomy or mineralocorticoid antagonists in patients with primary aldosteronism Hypertension 50 911 918 1:CAS:528:DC%2BD2sXhtFGjur7F 10.1161/HYPERTENSIONAHA.107.095448 17893375 This paper provides information on the effects of adrenalectomy and treatment with MR antagonists on left ventricular mass index (Pubitemid 350287534)
16. RD Gordon MD Ziesak TJ Tunny, et al. 1993 Evidence that primary aldosteronism may not be uncommon: 12% incidence among antihypertensive drug trial volunteers Clin Exp Pharmacol Physiol 20 296 298 1:CAS:528: DyaK3sXksVKmsLw%3D 10.1111/j.1440-1681.1993.tb01687.x 8324912
17. GH Anderson Jr 1994 Blakeman N, Streeten DH: The effect of age on prevalence of secondary forms of hypertension in 4429 consecutively referred patients J Hypertens 12 609 615 10.1097/00004872-199405000-00015 7930562 (Pubitemid 24192887)
18. RD Gordon M Stowasser TJ Tunny, et al. 1994 High incidence of primary aldosteronism in 199 patients referred with hypertension Clin Exp Pharmacol Physiol 21 315 318 1:STN:280:DyaK2M%2FgvVelsw%3D%3D 10.1111/j.1440-1681.1994. tb02519.x 7923898
19. GP Rossi E Rossi E Pavan, et al. 1998 Screening for primary aldosteronism with a logistic multivariate discriminant analysis Clin Endocrinol (Oxf) 49 713 723 1:STN:280:DyaK1M3is1SgsQ%3D%3D 10.1046/j.1365-2265.1998.00608.x (Pubitemid 29009500)
20. GP Rossi 2004 Primary aldosteronism: a needle in a haystack or a yellow cab on Fifth Avenue? Curr Hypertens Rep 6 1 4 10.1007/s11906-004-0001-0 14972082
21. GP Rossi AC Pessina AM Heagerty 2008 Primary aldosteronism: an update on screening, diagnosis and treatment J Hypertens 26 613 621 1:CAS:528: DC%2BD1cXivFOqurg%3D 10.1097/HJH.0b013e3282f4b3e6 18327065 (Pubitemid 351354903)
22. GP Rossi TM Seccia AC Pessina 2007 Clinical use of laboratory tests for the identification of secondary forms of arterial hypertension Crit Rev Clin Lab Sci 44 1 85 1:CAS:528:DC%2BD2sXhvVanu7s%3D 10.1080/10408360600931831 17175520 This review article provides updated information on laboratory tests, including the renin and aldosterone assay, for identifying the secondary forms of arterial hypertension (Pubitemid 44973616)
23. JW Funder RM Carey C Fardella, et al. 2008 Case detection, diagnosis, and treatment of patients with primary aldosteronism: an Endocrine Society clinical practice guideline J Clin Endocrinol Metab 93 3266 3281 1:CAS:528: DC%2BD1cXhtFChurrI 10.1210/jc.2008-0104 18552288
24. GP Rossi G Bernini C Caliumi, et al. 2006 A prospective study of the prevalence of primary aldosteronism in 1, 125 hypertensive patients J Am Coll Cardiol 48 2293 2300 1:CAS:528:DC%2BD28Xht12ks7%2FK 10.1016/j.jacc.2006.07.059 17161262 (Pubitemid 44873058)
25. GP Rossi A Belfiore G Bernini, et al. 2008 Body mass index predicts plasma aldosterone concentrations in overweight-obese primary hypertensive patients J Clin Endocrinol Metab 93 2566 2571 1:CAS:528:DC%2BD1cXoslykur0%3D 10.1210/jc.2008-0251 18445663 (Pubitemid 352008521)
26. JE Sealey RD Gordon F Mantero 2005 Plasma renin and aldosterone measurements in low renin hypertensive states Trends Endocrinol Metab 16 86 91 1:CAS:528:DC%2BD2MXivV2gsrY%3D 10.1016/j.tem.2005.02.006 15808804 (Pubitemid 40432456)
27. DJ Campbell J Nussberger M Stowasser, et al. 2009 Activity assays and immunoassays for plasma renin and prorenin: information provided and precautions necessary for accurate measurement Clin Chem 55 867 877 1:CAS:528: DC%2BD1MXlsVWmtr4%3D 10.1373/clinchem.2008.118000 19264850
28. Rossi GP, Barisa M, Belfiore A, et al.: The aldosterone renin ratio based on the plasma renin activity and the direct renin assay for diagnosing aldosterone-producing adenoma. J Hypertens 2010 (in press). This paper provides information on the performance of the direct renin assay as compared with the plasma renin assay for the identification of APA.
29. M Stowasser RD Gordon TG Gunasekera, et al. 2003 High rate of detection of primary aldosteronism, including surgically treatable forms, after "non-selective" screening of hypertensive patients J Hypertens 21 2149 2157 1:CAS:528:DC%2BD3sXos1amu74%3D 10.1097/00004872-200311000-00025 14597859 (Pubitemid 38296877)
30. GP Rossi TM Seccia G Palumbo, et al. 2010 Within-patient reproducibility of the aldosterone:renin ratio in primary aldosteronism Hypertension 55 83 89 1:CAS:528:DC%2BD1MXhsFaqt7fO 10.1161/HYPERTENSIONAHA.109.139832 19933925 This paper investigated the reproducibility of the ARR when repeated in the same patients under standardized conditions
31. I Irony CE Kater EG Biglieri CH Shackleton 1990 Correctable subsets of primary aldosteronism. Primary adrenal hyperplasia and renin responsive adenoma Am J Hypertens 3 576 582 1:STN:280:DyaK3czgtlKruw%3D%3D 2194512
32. RD Gordon CE Gomez-Sanchez SM Hamlet, et al. 1987 Angiotensin-responsive aldosterone-producing adenoma masquerades as idiopathic hyperaldosteronism (IHA: adrenal hyperplasia) or low-renin hypertension J Hypertens Suppl 5 Suppl 5 S103 S106 1:STN:280:DyaL1c7ntFyjtA%3D%3D 2832571
33. GP Rossi A Belfiore G Bernini, et al. 2007 Comparison of the captopril and the saline infusion test for excluding aldosterone-producing adenoma Hypertension 50 424 431 1:CAS:528:DC%2BD2sXnsFOjtrs%3D 10.1161/HYPERTENSIONAHA. 107.091827 17592070 This study compared head-to-head the captopril and the saline infusion tests for excluding APA under different sodium intakes (Pubitemid 47205795)
34. GP Rossi M Chiesura-Corona A Tregnaghi, et al. 1993 Imaging of aldosterone-secreting adenomas: a prospective comparison of computed tomography and magnetic resonance imaging in 27 patients with suspected primary aldosteronism J Hum Hypertens 7 357 363 1:STN:280:DyaK2c%2Fhs1ansQ%3D%3D 8410926
35. GP Rossi R Vendraminelli M Cesari AC Pessina 2000 A thoracic mass with hypertension and hypokalaemia [case report] Lancet 356 1570 1:STN:280: DC%2BD3M%2Fks1Oitg%3D%3D 10.1016/S0140-6736(00)03129-9 11075772
36. TM Seccia A Fassina GG Nussdorfer, et al. 2005 Aldosterone-producing adrenocortical carcinoma: an unusual cause of Conn's syndrome with an ominous clinical course Endocr Relat Cancer 12 149 159 10.1677/erc.1.00867 15788646 (Pubitemid 40477095)
37. M Omura H Sasano T Fujiwara, et al. 2002 Unique cases of unilateral hyperaldosteronemia due to multiple adrenocortical micronodules, which can only be detected by selective adrenal venous sampling Metabolism 51 350 355 1:CAS:528:DC%2BD38XitV2rt7k%3D 10.1053/meta.2002.30498 11887172 (Pubitemid 34232637)
38. SB Magill H Raff JL Shaker, et al. 2001 Comparison of adrenal vein sampling and computed tomography in the differentiation of primary aldosteronism J Clin Endocrinol Metab 86 1066 1071 1:CAS:528:DC%2BD3MXitFWnsLY%3D 10.1210/jc.86.3.1066 11238487 (Pubitemid 32322983)
39. F Mantero M Terzolo G Arnaldi, et al. 2000 A survey on adrenal incidentaloma in Italy. Study Group on Adrenal Tumors of the Italian Society of Endocrinology J Clin Endocrinol Metab 85 637 644 1:CAS:528:DC%2BD3cXhtlyhurw%3D 10.1210/jc.85.2.637 10690869 (Pubitemid 32273647)
40. WF Young AW Stanson GB Thompson, et al. 2004 Role for adrenal venous sampling in primary aldosteronism Surgery 136 1227 1235 10.1016/j.surg.2004.06. 051 15657580 (Pubitemid 39647538)
41. MJ Kempers JW Lenders L van Outheusden, et al. 2009 Systematic review: diagnostic procedures to differentiate unilateral from bilateral adrenal abnormality in primary aldosteronism Ann Intern Med 151 329 337 19721021 This study is a meta-analysis of different procedures used for differentiation of PA subtypes
42. GP Rossi 2007 New concepts in adrenal vein sampling for aldosterone in the diagnosis of primary aldosteronism Curr Hypertens Rep 9 90 97 1:CAS:528:DC%2BD2sXhtVenurzN 10.1007/s11906-007-0017-3 17442218 (Pubitemid 46779372)
43. GP Rossi G Pitter P Bernante, et al. 2008 Adrenal vein sampling for primary aldosteronism: the assessment of selectivity and lateralization of aldosterone excess baseline and after adrenocorticotropic hormone (ACTH) stimulation J Hypertens 26 989 997 1:CAS:528:DC%2BD1cXktl2rtbs%3D 10.1097/HJH.0b013e3282f9e66a 18398342 (Pubitemid 351520987)
44. N Daunt 2005 Adrenal vein sampling: how to make it quick, easy, and successful Radiographics 25 Suppl 1 S143 S158 10.1148/rg.25si055514 16227488 (Pubitemid 41686069)
45. GP Rossi A Sacchetto M Chiesura-Corona, et al. 2001 Identification of the etiology of primary aldosteronism with adrenal vein sampling in patients with equivocal computed tomography and magnetic resonance findings: results in 104 consecutive cases J Clin Endocrinol Metab 86 1083 1090 1:CAS:528: DC%2BD3MXitFWnsbw%3D 10.1210/jc.86.3.1083 11238490 (Pubitemid 32322986)
46. GP Rossi C Ganzaroli D Miotto, et al. 2006 Dynamic testing with high-dose adrenocorticotrophic hormone does not improve lateralization of aldosterone oversecretion in primary aldosteronism patients J Hypertens 24 371 379 1:CAS:528:DC%2BD28Xhslamuro%3D 10.1097/01.hjh.0000202818.10459.96 16508586 (Pubitemid 43348251)
47. GP Rossi G Pitter D Miotto 2007 To stimulate or not to stimulate: is adrenocorticotrophic hormone testing necessary, or not? Round 2 J Hypertens 25 1518 1520 1:CAS:528:DC%2BD2sXmtlWnt7c%3D 10.1097/HJH.0b013e3281c4a006 (Pubitemid 46918848)
48. TM Seccia D Miotto R De Toni, et al. 2009 Adrenocorticotropic hormone stimulation during adrenal vein sampling for identifying surgically curable subtypes of primary aldosteronism: comparison of 3 different protocols Hypertension 53 761 766 1:CAS:528:DC%2BD1MXksFeitbk%3D 10.1161/HYPERTENSIONAHA. 108.128553 19349554
49. D Miotto R De Toni G Pitter, et al. 2009 Impact of accessory hepatic veins on adrenal vein sampling for identification of surgically curable primary aldosteronism Hypertension 54 885 889 1:CAS:528:DC%2BD1MXhtFSns7vP 10.1161/HYPERTENSIONAHA.109.134759 19687347 This study described the impact of the presence of accessory hepatic veins on the right side on the results of AVS and highlighted the importance of superselective catheterization when such variants are identified
50. A Toniato P Bernante GP Rossi, et al. 2000 Laparoscopic versus open adrenalectomy: outcome in 35 consecutive patients Int J Surg Investig 1 503 507 1:STN:280:DC%2BD3MnotlajtA%3D%3D 11729858